Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Female
Breast Neoplasms, Fatigue
Female
Breast Neoplasms, Fatigue
Trial Information
Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients
Inclusion Criteria:
- non-metastatic invasive breast cancer
- currently receiving adjuvant chemotherapy
- moderate to severe chemotherapy-induced fatigue
- physical and cognitive capacity to participate in yoga or walking
Exclusion Criteria:
- diagnosed and pharmacologically treated psychiatric disorder except depressive
adaptation disorder as a reaction to cancer diagnosis
- ECOG status > 1
- prior malignancy with a disease-free survival < 10 years except curatively treated
basalioma of the skin and carcinoma in situ of the cervix
- prior ductal carcinoma in situ (DCIS) ot the breast
- pregnancy or breastfeeding
- regular practice of yoga or walking during the past 12 months
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Fatigue
Outcome Description:
Multidimensional Fatigue Inventory
Outcome Time Frame:
Week 12
Safety Issue:
No
Principal Investigator
Holger Cramer, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Duisburg-Essen, Chair of Complementary and Integrative Medicine
Authority:
Germany: Ethics Commission
Study ID:
2012210
NCT ID:
NCT01686737
Start Date:
November 2012
Completion Date:
July 2014
Related Keywords:
- Breast Neoplasms
- Fatigue
- Breast Neoplasms
- Neoplasms
- Fatigue
Name | Location |
|---|
